Remove Diabetes Remove Pharmaceutical Companies Remove Pharmaceutical Manufacturing
article thumbnail

Kashmik Formulation plans 50 per cent production capacity expansion and targets ₹100 crore revenue in FY26

Express Pharma

To support this, the company is investing approximately ₹20 crore in infrastructure development, which is already underway. The company generates around 70 per cent of its revenue from its own branded generics and 20–30 per cent from contract manufacturing for established pharmaceutical companies.

article thumbnail

AI-driven drug discovery, precision medicine, and sustainable manufacturing can redefine the pharma industry

Express Pharma

What are the top 3 trends that defined pharma manufacturing in India and globally in 2024? In 2024, the pharmaceutical manufacturing landscape underwent transformative changes, driven by technological innovations, regulatory adaptations, and evolving global demands.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Key Trends Reshaping Pharmaceutical Market Access in 2025

Pharma Leaders

Pharmaceutical companies can leverage these tools to gather real-world evidence, personalize treatments, and improve the patient experience. By diversifying their approach, manufacturers aim to preserve GTN and ensure long-term business sustainability.

article thumbnail

Understanding Recent Changes to 505(b)(2) Drugs and Reimbursement

Pharmacy Times

For submission consideration, manufacturers can petition the FDA for ANDA status if the requested change does not require safety or effectiveness studies. It is basically an essential copy, and the pharmaceutical manufacturer has to show bioequivalence to the reference product,” Soefje said. “If

article thumbnail

Exclusive Coverage: Global PHT Expo & Summit 2023

PharmaShots

The speakers shared their views on the topic: Dr. Jagadeesh Babu Rangisetty- “COVID has taught us so many things and the pharmaceutical company has gone through a lot of challenges and at the same time opportunities. According to me the main issue faced during the pandemic was the supply chain of pharmaceuticals.

article thumbnail

Sanofi to sell Japanese manufacturing plant

European Pharmaceutical Review

Sanofi has signed definitive agreements with Adragos Pharmaceutical, a German contract development and manufacturing organisation (CDMO), for the sale of its pharmaceutical manufacturing site in Kawagoe, Japan. The French pharmaceutical company will also enter into a long-term supply agreement with the CDMO.

article thumbnail

‘Right shoring’ API production in Europe

Pharmaceutical Technology

In the 1990s, generic pharmaceutical companies in the European Union (EU) offshored the manufacturing of active pharmaceutical ingredients (API) primarily to China. Moreover, US Pharmacopeia issued the first-ever Medicine Supply Map to find and quantify risks in upstream pharmaceutical supply chains across the country.